Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR T) therapy has demonstrated remarkable efficacy in patients with relapsed/refractory multiple myeloma, and now there are two US Food and Drug Administration-approved BCMA-directed CAR T products. However, despite high in...

全面介紹

Saved in:
書目詳細資料
Main Authors: Oliver Van Oekelen, Karthik Nath, Tarek H. Mouhieddine, Tasmin Farzana, Adolfo Aleman, David T. Melnekoff, Yogita Ghodke‐Puranik, Gunjan L. Shah, Alexander M. Lesokhin, Sergio Giralt, Santiago Thibaud, Adriana Rossi, Cesar Rodriguez, Larysa Sanchez, Joshua Richter, Shambavi Richard, Hearn Jay Cho, Ajai Chari, Saad Z. Usmani, Sundar Jagannath, Urvi A. Shah, Sham Mailankody, Samir Parekh
格式: Artigo
語言:英语
出版: 2022
在線閱讀:https://doi.org/10.1182/blood.2022017848
https://ashpublications.org/blood/article-pdf/141/7/756/2034470/blood_bld-2022-017848-main.pdf
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!